M4MM
Helus Pharma Rings Nasdaq Bell Post-Cybin Rebrand
TORONTO – Helus Pharma Inc., rebranded from Cybin Inc., opened trading on the Nasdaq Global Market under the ticker symbol $HELP, marking a shift from the NYSE American where it previously traded as $CYBN. The ...
Who Will Decide Cannabis Legalization? The Math Will.
LOS ANGELES -For decades, Cannabis reform in the United States has moved unevenly—state by state, ballot by ballot, crisis by crisis. On paper, federal prohibition still stands, and national politics remain polarized. But economically and ...
Canopy Growth Locks in Debt Overhaul, Gears Up for Expansion
TORONTO – Canopy Growth Corp. detailed a pair of financial maneuvers aimed at shoring up its books and clearing a path for expansion. The deals, which include a new $150 million U.S. term loan and ...
Vireo Takes 86% Stake in Schwazze’s Convertible Notes in $62M Deal
DENVER – Vireo Growth Inc., a multistate Cannabis operator, has entered into definitive agreements to purchase about 86% of the senior secured convertible notes held by Medicine Man Technologies Inc., which operates as Schwazze, for ...
France Upholds Pesticide Ban, Guaranteeing Survival of the Bees
LOS ANGELES- Over the past decade, France has stood at the center of Europe’s fight to protect pollinators from the devastating effects of pesticides. In 2018, the nation became the first EU member to ban ...
OPINION: The People Have Spoken: It’s Time to End Federal Cannabis Prohibition (and Release the Epstein Files)
LOS ANGELES- With 87% of Americans supporting Cannabis legalization — and nearly 80% demanding the release of the Epstein files — public consensus on reform and transparency has never been stronger. The question now is ...
How Professional Services Firms That Serve Cannabis Can Thrive in the Wellness Industry
NEW YORK- Professional service providers — from accountants and attorneys to brand strategists and tech consultants — have played an indispensable role in legitimizing and professionalizing the Cannabis sector. These same firms now have a ...
Helus Pharma Rings Nasdaq Bell Post-Cybin Rebrand
TORONTO – Helus Pharma Inc., rebranded from Cybin Inc., opened trading on the Nasdaq Global Market under the ticker symbol $HELP, marking a shift from the NYSE American where it previously traded as $CYBN. The ...
Who Will Decide Cannabis Legalization? The Math Will.
LOS ANGELES -For decades, Cannabis reform in the United States has moved unevenly—state by state, ballot by ballot, crisis by crisis. On paper, federal prohibition still stands, and national politics remain polarized. But economically and ...
Canopy Growth Locks in Debt Overhaul, Gears Up for Expansion
TORONTO – Canopy Growth Corp. detailed a pair of financial maneuvers aimed at shoring up its books and clearing a path for expansion. The deals, which include a new $150 million U.S. term loan and ...
Canadian Cannabis Advocates Push for Higher THC Limits in Edibles Amid Regulatory Review
NEW YORK- In a significant development in Canada's cannabis landscape, advocates are pressing the federal government to revise the potency limits for cannabis edibles. A petition launched last week is seeking a tenfold increase in ...
TerrAscend Corp. Raises Revenue Guidance, Sees Robust Growth in Multiple States
LOS ANGELES-- TerrAscend Corp. displayed a strong financial posture by updating its revenue guidance for 2023 during its investor day at the Toronto Stock Exchange. This adjustment propelled the company's stock upwards by 4%, resulting ...
Tilray Medical Engages in Glioblastoma Research Through Clinical Trial in Spain
LOS ANGELES-- In a significant stride for the medical cannabis community, Tilray Medical, an affiliate of Tilray Brands, Inc., declared its involvement in a groundbreaking clinical trial slated to delve into the therapeutic potential of ...
Trulieve Cannabis Corp. Seeks $143 Million Tax Refund Amidst Dispute Over 280E Obligations
LOS ANGELES- U.S. cannabis titan, Trulieve Cannabis Corp, has lodged a claim for a $143 million tax refund from the federal government. The refund pertains to payments the firm made during the fiscal years 2019, ...
FDA Warns Against Unsupervised Use of Ketamine for Psychiatric Disorders
WASHINGTON, D.C. — The U.S. Food and Drug Administration (FDA) has raised concerns over the unsupervised and unauthorized use of compounded ketamine and ketamine-based drugs for treating psychiatric conditions. In a recent alert, the FDA ...
Connecticut’s Cannabis Sales Soar, Surpassing $15 Million Mark for Adult-use Alone
HARTFORD, CT — Connecticut's blossoming cannabis market has reached with combined sales of adult-use and medical marijuana crossing $25 million in September 2023, according to the state's Department of Consumer Protection (DCP). This surge in ...
Colorado Cannabis Sales Surpass $15 Billion, But Recent Trends Raise Concerns
DENVER — August witnessed Colorado's recreational cannabis market and its established medical marijuana industry reach a significant landmark, achieving over $15 billion in cumulative sales since the inauguration of the adult-use market in January 2014. ...
U.S. Cannabis Banking Reform Faces New Hurdles Amid Political Drama
WASHINGTON D.C. — Recent optimism surrounding potential U.S. cannabis banking reform has encountered obstacles, with unrelated political issues clouding prospects for legislative passage. While there is hope for the U.S. Senate to pass the SAFER ...
Canada’s Cannabis Industry Faces Economic Challenges, Says Health Canada Report
OTTAWA — A recent report by the Canadian government suggests the nation's legal cannabis industry is encountering significant economic challenges, shedding light on the realities faced by businesses after the 2018 legalization. The report, titled ...
ANALYSIS: Cannabis Payments: Navigating a Landscape of Opportunities and Pitfalls
NEW YORK — Cannabis payment systems have always been rife with controversy and uncertainty. As we explore the landscape, the focus is primarily on services purporting to have a compliant mechanism to accept credit cards. ...
FSD Pharma Wins Legal Battle Against Former CEO; Ventures into Dietary Supplements
NEW YORK — In a significant legal triumph, FSD Pharma Inc. a Canadian biopharmaceutical firm, received a favorable ruling from the Ontario Superior Court of Justice on Thursday against its former chief executive, Dr. ...
Atai Life Sciences Bolsters Investment in IntelGenx Technologies
NEW YORK — Atai Life Sciences AG's (Nasdaq: ATAI) confidence in IntelGenx Technologies Corp. (OTC: IGXT) seems unwavering as its investments in the pharmaceutical firm grow. The robust belief in IntelGenx's medical technology continues to ...
New Mexico’s Cannabis Microbusiness License Fees May Rise
NEW YORK — Cannabis microbusinesses in New Mexico may soon face a hike in their annual license fees, should proposed rule changes be ratified after a public comment period. A slated policy revision by the ...
New Jersey Boosts Cannabis Industry with $12 Million in Equity Grants
LOS ANGELES — In a significant push to bolster its nascent cannabis sector, the New Jersey Economic Development Authority (NJEDA) announced a $12 million grant award to 48 marijuana enterprises as part of the state's ...
California Governor Vetoed Cannabis Cafe Bill, Citing Smoke-Free Concerns
LOS ANGELES — Governor Gavin Newsom has placed a halt on the proposed move to introduce Amsterdam-style cannabis cafes in California. Despite significant bipartisan backing, Assembly Bill 374, the bill that could have potentially transformed ...
